Ardent Health Partners, Inc. (ARDT) AI Stock Analysis

• Market Cap: $2.08B
• Dividend Yield: N/A
• Average Volume (3M): 407.60K
• Price to Earnings (P/E): 8.1
• Beta (1Y): 0.51
• Revenue Growth: 10.03%
• EPS Growth: 197.26%
• Country: US
• Employees: 19,200
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): 0.52
• Shares Outstanding: 143,106,450
• 10 Day Avg. Volume: 333,763
• 30 Day Avg. Volume: 407,603
• PEG Ratio: 0.03
• Price to Book (P/B): 2.00
• Price to Sales (P/S): 0.38
• P/FCF Ratio: 17.74
• Enterprise Value/Market Cap: 1.94
• Enterprise Value/Revenue: 0.65
• Enterprise Value/Gross Profit: 1.07
• Enterprise Value/Ebitda: 6.58
• 1Y Price Target: $17.84
• Price Target Upside: 23.89% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 6
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 71 Outperform
• Price Target: $14.00 ▼(-2.78% Downside)

Ardent Health Partners, Inc. scores well due to strong financial performance and attractive valuation. The stock's bullish technical indicators are tempered by overbought signals, suggesting caution. The absence of earnings call data and corporate events does not impact the score significantly.

Positive Factors

Revenue Growth

Consistent revenue growth indicates robust demand for services and effective market positioning, supporting long-term financial health.

Profitability Improvement

Improved profitability reflects effective cost management and operational efficiency, enhancing the company's ability to reinvest in growth.

Cash Flow Generation

Strong cash flow generation enhances financial flexibility, allowing for strategic investments and debt reduction, supporting long-term stability.

Negative Factors

Debt Reliance

High reliance on debt can increase financial risk and limit flexibility, potentially impacting the company's ability to navigate economic downturns.

Operational Efficiency

Suboptimal operational efficiency may hinder profitability and competitiveness, necessitating improvements to sustain long-term growth.

Free Cash Flow Conversion

Limited free cash flow conversion could constrain liquidity, affecting the company's ability to fund operations and growth initiatives.

Ardent Health Partners, Inc. Business Overview & Revenue Model

Company Description

Ardent Health Partners, LLC owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, LLC is a subsidiary of EGI-AM Investments, L.L.C.

How the Company Makes Money

Ardent Health Partners generates revenue primarily through the provision of healthcare services, which include inpatient and outpatient care, surgical services, emergency services, and rehabilitation services. The company's revenue model is largely based on reimbursements from government programs such as Medicare and Medicaid, as well as private insurance payers. Key revenue streams include patient services revenue, which accounts for the majority of its income, and ancillary services like laboratory and imaging services, which provide additional financial support. Ardent Health also engages in strategic partnerships with other healthcare organizations and participates in value-based care initiatives that can lead to shared savings and improved reimbursement rates. These factors, combined with a focus on operational efficiency and patient satisfaction, contribute to the company's overall financial performance.

Ardent Health Partners, Inc. Financial Statement Overview

Summary

Ardent Health Partners, Inc. exhibits strong revenue growth and improved profitability, supported by a stable balance sheet and robust cash flow generation. Effective cost management and shareholder returns are evident, though there are areas for improvement in operational efficiency and liquidity management. The reliance on debt financing poses a potential risk.

Income Statement

Ardent Health Partners, Inc. has shown strong revenue growth with a 10.29% increase from 2023 to 2024. The gross profit margin is robust at 57.51% for 2024, indicating effective cost management. The net profit margin improved significantly to 3.53% in 2024 from 0.93% in 2023, reflecting enhanced profitability. However, the EBIT and EBITDA margins, at 6.80% and 9.32% respectively, suggest room for improvement in operational efficiency.

Balance Sheet

The company's balance sheet shows a moderate debt-to-equity ratio of 1.50, indicating a balanced approach to leveraging. Return on equity improved to 13.83% in 2024, showcasing effective use of shareholder funds. The equity ratio stands at 30.69%, which is reasonable but suggests a reliance on debt financing. Overall, the balance sheet reflects stability with potential risks from leverage.

Cash Flow

Ardent Health Partners, Inc. has demonstrated a positive free cash flow growth rate of 51.26% from 2023 to 2024, indicating strong cash generation capabilities. The operating cash flow to net income ratio is 1.50, suggesting efficient cash conversion. However, the free cash flow to net income ratio is 0.61, indicating that not all net income is translating into free cash flow, which could be a concern for liquidity.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2018	Dec 2017
Income Statement
Total Revenue	6.20B	5.97B	5.41B	5.13B	4.16B	3.00B
Gross Profit	3.79B	3.43B	5.27B	4.17B	4.16B	3.00B
EBITDA	615.44M	555.92M	350.00M	531.70M	281.84M	230.91M
Net Income	254.86M	210.34M	50.29M	188.91M	-143.02M	-35.65M
Balance Sheet
Total Assets	5.03B	4.96B	4.73B	4.86B	2.75B	2.37B
Cash, Cash Equivalents and Short-Term Investments	540.63M	556.78M	437.58M	456.12M	59.66M	71.96M
Total Debt	2.27B	2.28B	2.40B	2.39B	1.26B	952.69M
Total Liabilities	3.38B	3.43B	3.65B	3.81B	2.03B	1.61B
Stockholders Equity	1.25B	1.13B	670.90M	639.05M	331.64M	377.72M
Cash Flow
Free Cash Flow	108.13M	127.52M	84.29M	-189.47M	-1.07M	-2.06M
Operating Cash Flow	301.98M	315.03M	221.70M	-38.36M	159.59M	119.47M
Investing Cash Flow	-219.32M	-220.46M	-137.98M	46.58M	-525.11M	-983.27M
Financing Cash Flow	123.43M	24.64M	-102.26M	-270.33M	353.22M	843.15M

Ardent Health Partners, Inc. Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 14.40
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ARDT, the sentiment is Neutral. The current price of 14.4 is below the 20-day moving average (MA) of 14.69, above the 50-day MA of 13.88, and above the 200-day MA of 13.52, indicating a neutral trend. The MACD of 0.19 indicates Positive momentum. The RSI at 49.69 is Neutral, neither overbought nor oversold. The STOCH value of 21.32 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for ARDT.

Ardent Health Partners, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
NHC	73 Outperform	$1.94B	18.63	10.65%	1.97%	25.19%	13.44%
ARDT	71 Outperform	$2.08B	8.12	25.56%	―	10.03%	197.26%
SEM	67 Neutral	$1.66B	15.35	5.57%	1.79%	-22.96%	-59.35%
ACHC	58 Neutral	$1.87B	16.55	3.49%	―	4.58%	-61.50%
BKD	56 Neutral	$2.20B	―	-108.91%	―	3.99%	-14.74%
AVAH	54 Neutral	$1.92B	114.76	―	―	15.48%	―
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Ardent Health Partners, Inc. Corporate Events

Ardent Health Partners Amends Credit Agreements for Flexibility

On September 18, 2025, Ardent Health, Inc., along with its subsidiary AHP Health Partners, Inc., and other related parties, entered into significant amendments to their existing credit agreements with Bank of America and other financial institutions. The amendments included refinancing outstanding term loans, extending the maturity date to September 18, 2032, reducing interest rates by 50 basis points, and updating certain financial covenants. These changes are expected to improve the company’s financial flexibility and reduce borrowing costs.

The most recent analyst rating on (ARDT) stock is a Buy with a $14.00 price target. To see the full list of analyst forecasts on Ardent Health Partners, Inc. stock, see the ARDT Stock Forecast page.

Ardent Health Reports Strong Q2 2025 Results

Ardent Health Partners, Inc. is a prominent healthcare provider operating in mid-sized urban communities across the United States, focusing on innovative services and technologies to improve healthcare accessibility. In its second quarter of 2025, Ardent Health reported a strong financial performance with a total revenue of $1.65 billion, marking an 11.9% increase year-over-year. The company’s net income attributable to Ardent Health reached $73 million, while adjusted EBITDA saw a significant 38.9% growth to $170 million. Key operational highlights include a 6.6% increase in admissions and a 10.2% rise in net patient service revenue per adjusted admission. The company also reaffirmed its 2025 financial guidance, projecting total revenue between $6.2 billion and $6.45 billion, and adjusted EBITDA between $575 million and $615 million. Ardent Health continues to advance its strategic initiatives, including the deployment of virtual nursing and AI-enabled scribe technologies, and plans to expand its ambulatory services with new urgent care and imaging centers. Looking ahead, Ardent Health remains committed to sustaining its growth momentum and operational excellence, as reflected in its reaffirmed guidance for the remainder of 2025.